Your browser doesn't support javascript.
loading
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY).
Bancroft, Elizabeth K; Saya, Sibel; Brown, Emma; Thomas, Sarah; Taylor, Natalie; Rothwell, Jeanette; Pope, Jennifer; Chamberlain, Anthony; Page, Elizabeth; Benafif, Sarah; Hanson, Helen; Dias, Alexander; Mikropoulos, Christos; Izatt, Louise; Side, Lucy; Walker, Lisa; Donaldson, Alan; Cook, Jackie A; Barwell, Julian; Wiles, Vicki; Limb, Lauren; Eccles, Diana M; Leach, Martin O; Shanley, Susan; Gilbert, Fiona J; Gallagher, David; Rajashanker, Balashanmugam; Whitehouse, Richard W; Koh, Dow-Mu; Sohaib, S Aslam; Evans, D Gareth; Eeles, Rosalind A; Walker, Leslie G.
Afiliación
  • Bancroft EK; Oncogenetics Team, The Royal Marsden NHS Foundation Trust, London, UK elizabeth.bancroft@rmh.nhs.uk.
  • Saya S; Oncogenetics Team, The Institute of Cancer Research, London, UK.
  • Brown E; Oncogenetics Team, The Institute of Cancer Research, London, UK.
  • Thomas S; Centre for Cancer Research & Department of General Practice, University of Melbourne, Melbourne, Victoria, Australia.
  • Taylor N; Medical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Rothwell J; Oncogenetics Team, The Royal Marsden NHS Foundation Trust, London, UK.
  • Pope J; Oncogenetics Team, The Royal Marsden NHS Foundation Trust, London, UK.
  • Chamberlain A; Clinical Genetics, Manchester University NHS Foundation Trust, Manchester, UK.
  • Page E; Oncogenetics Team, The Institute of Cancer Research, London, UK.
  • Benafif S; Oncogenetics Team, The Institute of Cancer Research, London, UK.
  • Hanson H; Oncogenetics Team, The Institute of Cancer Research, London, UK.
  • Dias A; Oncogenetics Team, The Institute of Cancer Research, London, UK.
  • Mikropoulos C; South West Thames Regional Genetics Service, St Georges NHS Foundation Trust, London, UK.
  • Izatt L; Oncogenetics Team, The Institute of Cancer Research, London, UK.
  • Side L; St Luke's Cancer Centre, Royal Surrey County Hospital, Guildford, UK.
  • Walker L; Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Donaldson A; Clinical Genetics, Wessex Clinical Genetics Service, Southampton, UK.
  • Cook JA; Clinical Genetics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Barwell J; Clinical Genetics, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Wiles V; Department of Clinical Genetics, Sheffield Children's Hospital, Sheffield, UK.
  • Limb L; Clinical Genetics, University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Eccles DM; Clinical Genetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Leach MO; North West Thames Regional Genetics Service (Kennedy-Galton Centre), London North West University Healthcare NHS Trust, Harrow, UK.
  • Shanley S; Cancer Sciences, University of Southampton Faculty of Medicine, Southampton, UK.
  • Gilbert FJ; Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust, London, UK.
  • Gallagher D; Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Rajashanker B; Formerly at the Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Whitehouse RW; Department of Radiology, University of Cambridge, Cambridge, UK.
  • Koh DM; Cancer Genetics Service, Mater Hospital School, Dublin, Ireland.
  • Sohaib SA; Radiology, Manchester Royal Infirmary, Manchester, UK.
  • Evans DG; Radiology, St Mary's Hospital, Manchester, UK.
  • Eeles RA; Radiology, Manchester Royal Infirmary, Manchester, UK.
  • Walker LG; Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust, London, UK.
J Med Genet ; 57(4): 226-236, 2020 04.
Article en En | MEDLINE | ID: mdl-31719169
ABSTRACT

BACKGROUND:

Germline TP53 gene pathogenic variants (pv) cause a very high lifetime risk of developing cancer, almost 100% for women and 75% for men. In the UK, annual MRI breast screening is recommended for female TP53 pv carriers. The SIGNIFY study (Magnetic Resonance Imaging screening in Li Fraumeni syndrome An exploratory whole body MRI) study reported outcomes of whole-body MRI (WB-MRI) in a cohort of 44 TP53 pv carriers and 44 matched population controls. The results supported the use of a baseline WB-MRI screen in all adult TP53 pv carriers. Here we report the acceptability of WB-MRI screening and effects on psychosocial functioning and health-related quality of life in the short and medium terms.

METHODS:

Psychosocial and other assessments were carried out at study enrolment, immediately before MRI, before and after MRI results, and at 12, 26 and 52 weeks' follow-up.

RESULTS:

WB-MRI was found to be acceptable with high levels of satisfaction and low levels of psychological morbidity throughout. Although their mean levels of cancer worry were not high, carriers had significantly more cancer worry at most time-points than controls. They also reported significantly more clinically significant intrusive and avoidant thoughts about cancer than controls at all time-points. There were no clinically significant adverse psychosocial outcomes in either carriers with a history of cancer or in those requiring further investigations.

CONCLUSION:

WB-MRI screening can be implemented in TP53 pv carriers without adverse psychosocial outcomes in the short and medium terms. A previous cancer diagnosis may predict a better psychosocial outcome. Some carriers seriously underestimate their risk of cancer. Carriers of pv should have access to a clinician to help them develop adaptive strategies to cope with cancer-related concerns and respond to clinically significant depression and/or anxiety.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Imagen por Resonancia Magnética / Proteína p53 Supresora de Tumor / Síndrome de Li-Fraumeni / Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Genet Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Asunto principal: Imagen por Resonancia Magnética / Proteína p53 Supresora de Tumor / Síndrome de Li-Fraumeni / Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Genet Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido